Singlepoint Healthcare (Singlepoint) announces its acquisition of Healix, a national infusion services provider supporting physician-owned and ambulatory infusion centers across the United States. Healix manages over 220 physician-owned and ambulatory infusion centers across the U.S., helping providers deliver critical therapies in accessible outpatient settings. The acquisition is Singlepoint’s third in the last year, following The Boster Center for Multiple Sclerosis and IV Solutions which launched the company in July 2025. Singlepoint is backed by DFW Capital Partners, a New York-based investor focused on partnering with growth-oriented healthcare and business services companies.
Read the full article: Singlepoint Healthcare Acquires Healix, Expanding National Infusion Capabilities //
Source: https://www.prnewswire.com/news-releases/singlepoint-healthcare-acquires-healix-expanding-national-infusion-capabilities-302800385.html